Neurological disorders (NDDs) are heterogeneous diseases that affect the body’s autonomic, peripheral and central nervous system. They are considered public health burdens that negatively impact the lives of millions globally resulting in deaths and disabilities.

Recently, there has been an increasing interest in characterizing different genomic, transcriptomic and epigenomic markers that might characterize different NDDs and help in identifying patients at risk.

This issue will focus on any new cutting-edge research that aims at delving deeper into that field and identifying additional potential predictive factors that could also be promising drug targets. The main goal behind not specifying one NDD but opening it to any, is to have the chance to look into resemblances between different NDDs and see whether there are common underlying pathways that contribute to their pathogenesis. This might be helpful in therapeutically targeting common pathways specially in NDDs that could co-exist partially or fully.